Pors, Anders
Korzeniowska, Barbara
Rasmussen, Markus T.
Lorenzen, Christian V.
Rasmussen, Kaspar G.
Inglev, Rune
Philipps, Amalie
Zschornack, Eva
Freckmann, Guido
Weber, Anders
Hepp, Karl D.
Article History
Received: 7 January 2025
Accepted: 20 March 2025
First Online: 25 March 2025
Declarations
:
: A.P. and A.W. are inventors on a patent application related to this work filed by RSP Systems (GB2116869.5, 23 Nov. 2021). A.W. is an inventor of a patent filed by RSP Systems related to this work (US9,380,942,07 Jan 2010). A.P., B.K. M.T.R, C.V.L., K.G.R, R.I., A.Ph., and A.W. are employed by RSP Systems. G.F. is general manager and medical director of the Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT), which carries out clinical studies, e.g., with medical devices for diabetes therapy on its own initiative and on behalf of various companies. E.Z. is employed by IfDT. No other potential conflicts of interest relevant to this article were reported.
: Parts of this study were presented as a poster presentation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2024), Florence, Italy, 6–9 March 2024.